ENGNenGene Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of enGene Therapeutics Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENGNThis | $99M#8 | 0.6x#1 | 0.4x#1 | — | — | -112.7%#13 | — | -50.9%#9 | — | — | — | — |
| NMRA | $115M#1 | — | 2.6x#11 | — | — | -2.8%#7 | — | 532.2%#2 | -594.0%#4 | — | — | — |
| AVXL | $113M#2 | — | 1.0x#6 | — | — | -7.8%#8 | — | -41.2%#7 | — | — | — | — |
| OTLK | $112M#3 | — | — | 79.5x#6 | — | 17.2%#5 | -4744.3%#6 | — | -12.8%#2 | — | — | — |
| LENZ | $111M#4 | — | 0.6x#2 | 5.8x#5 | — | -65.0%#10 | -477.5%#5 | -42.8%#8 | — | — | — | — |
| VYGR | $111M#5 | — | 0.7x#3 | 2.7x#4 | -49.5%#4 | -84.2%#12 | -326.6%#4 | -77.6%#11 | — | — | — | — |
| ARMP | $109M#6 | — | — | — | — | -818.8%#15 | — | — | — | — | — | 0.1%#1 |
| BDTX | $103M#7 | — | 1.1x#7 | 1.5x#3 | — | 132.1%#1 | 17.9%#1 | 23276.9%#1 | — | — | -54.4%#4 | — |
| TNYA | $84M#9 | — | 1.2x#8 | — | — | 18.5%#4 | — | -130.5%#12 | — | — | — | — |
| VXRT | $80M#10 | 2.0x#2 | 1.0x#4 | 0.3x#1 | 726.7%#1 | 124.4%#2 | 7.6%#2 | 0.0%#3 | 22.5%#1 | — | -24.0%#2 | — |
| CSBR | $68M#11 | — | 17.5x#12 | 1.1x#2 | 4.4%#2 | -125.0%#14 | -1.9%#3 | -0.0%#4 | — | — | -27.6%#3 | — |
| CRDF | $66M#12 | — | 2.5x#10 | 112.0x#7 | -13.2%#3 | -0.9%#6 | -8256.3%#7 | -0.2%#5 | — | — | — | — |
| CGTX | $65M#13 | — | 2.0x#9 | — | — | 30.9%#3 | — | -71.1%#10 | — | — | — | — |
| GRMLW | $57M#14 | — | 1.0x#5 | — | — | -71.6%#11 | — | -18.2%#6 | -14.6%#3 | — | — | — |
| INKT | $55M#15 | — | — | — | — | -15.9%#9 | — | — | — | — | -23.4%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice